Medivolve Inc.

Equities

MEDVF

CA58503M4083

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 17:48:15 28/05/2024 BST			5-day change	1st Jan Change
0.0083 ^USD	+66.00%		+72.92%	-23.85%

04-02	Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01-16	Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer	CI

Questcap Inc. Announces the Appointment of Joseph Sugerman to the Advisory Board

May 01, 2020 at 01:00 pm

QuestCap Inc. announced that Joseph Sugerman has joined the QuestCap Advisory Board. As a well-regarded otolaryngologist, Dr. Sugerman will contribute substantial medical expertise to the QuestCap team of global experts engaged to advise on QuestCap’s investments in specialized industries, including innovative medical technologies.

Latest news about Medivolve Inc.

Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-02	CI
Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer	01-16	CI
Medivolve Inc. Announces Management Changes	01-16	CI
Medivolve Inc. Announces the Resignation of Wen Ye as Board of Director	11-17	CI
Medivolve Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Medivolve Inc. Announces the Resignation of Beverley Richardson from its Board of Directors	11-07	CI
Medivolve Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13/08/23	CI
Medivolve Inc. Establishes Medivolve Management Services, LLC in Puerto Rico	15/05/23	CI
Medivolve Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	14/05/23	CI
Medivolve Inc.'s Equity Buyback announced on May 3, 2022, has expired.	02/05/23	CI
Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	03/04/23	CI
Medivolve Inc. Auditor Raises 'Going Concern' Doubt	02/04/23	CI
Medivolve Inc. announced that it expects to receive CAD 4 million in funding	18/01/23	CI
Medivolve Inc. announced that it has received CAD 1.2 million in funding	10/01/23	CI
QuestCap Inc. cancelled the acquisition of a 40% stake in Spectral Analytics, Inc.	30/12/22	CI
Medivolve Inc. announced that it expects to receive CAD 1.2 million in funding	22/12/22	CI
Medivolve Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	13/11/22	CI
Medivolve Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	14/08/22	CI
Medivolve Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/05/22	CI
Medivolve Inc. (OTCPK:COPR.F) announces an Equity Buyback for 38,449,060 shares.	03/05/22	CI
Medivolve Inc. authorizes a Buyback Plan.	02/05/22	CI
Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	30/03/22	CI
Medivolve Inc. Announces Chief Financial Officer Changes	28/02/22	CI
Medivolve Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21	CI
Medivolve Inc. announced that it has received CAD 1.7 million in funding	08/11/21	CI

Chart Medivolve Inc.

Duration

Period

More charts

Company Profile

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSDâs software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.

Sector

Advanced Medical Equipment & Technology

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Software & Technology Services

	1st Jan change	Capi.
MEDIVOLVE INC.	-23.85%	135K
VEEVA SYSTEMS INC.	+5.49%	32.95B
PRO MEDICUS LIMITED	+19.28%	7.87B
SECTRA AB	+33.25%	4.35B
EVOLENT HEALTH, INC.	-30.09%	2.67B
OMNICELL, INC.	-13.90%	1.5B
VERADIGM INC.	-16.59%	1.27B
LUNIT INC.	-35.41%	1.16B
SIMULATIONS PLUS, INC.	+11.17%	996M
B-SOFT CO.,LTD.	-39.85%	859M

Medical Software & Technology Services